FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

BIOSPECIFICS TECHNOLOGIES CORP: cashflow_financing

One fact, its scope and the complete path back to the official record.

Period: 2019-01-01 – 2019-09-30Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/49038aa3-eb4b-4791-82fb-93a6d692ea5c

Reported value

$1.776M{"amount": 1776107, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Entity
BIOSPECIFICS TECHNOLOGIES CORP
Metric
cashflow_financing
Period
2019-01-01 – 2019-09-30
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001140361-19-020316 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T08:42:52.997357+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0000875622/cashflow-financing/2019-09-30 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.